Volume 16, Number 11—November 2010
Dispatch
Plasmid-mediated Quinolone Resistance among Non-TyphiSalmonella enterica Isolates, USA
Table
Isolate no. | S. enterica serovar | Submitting site | Resistance phenotype | Ciprofloxacin MIC, mg/L | aac6′Ib/qnr variant |
---|---|---|---|---|---|
AM31035 | Thompson | NY | AMP, SUL | 0.5 | aac(6′)-Ib-cr |
AM30827 | Typhimurium | CA | STR, SUL, TET | 0.5 | qnrS1 |
AM31228 | Corvallis | VA | ND | 0.5 | qnrS1 |
AM33914 | Typhimurium | NC | ND | 0.5 | qnrS1 |
AM31434 | Enteritidis | LX | SUL, SXT, TET | 0.25 | qnrB2 |
AM33097 | Beaudesert | CA | ND | 0.25 | qnrB19 |
*NARMS, National Antimicrobial Resistance Monitoring System; NY, New York; AMP, ampicillin; SUL, sulfamethoxazole or sulfisoxazole; CA, California; STR, streptomycin; TET, tetracycline; VA, Virginia; ND, none detected; NC, North Carolina; LX, Los Angeles; SXT, trimethoprim/sulfamethoxazole.
Page created: March 04, 2011
Page updated: March 04, 2011
Page reviewed: March 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.